VELLORE CHRISTIAN MEDICAL COLLEGE FOUNDATION

VELLORE CMC FOUNDATION

CMC Vellore Media Highlights

Coronavirus: Serum Institute gets approval for phase 2 and 3 human trials of Oxford vaccine

The Drug Controller General of India on Sunday granted permission to the Serum Institute of India in Pune to conduct phase two and three human clinical trials of the coronavirus vaccine candidate developed by Oxford University and British-Swedish pharmaceutical firm AstraZeneca, PTI reported. Read the full story at Scroll.in

Other CMC in the News

Learn More About

Gifts of Stocks & Securities
Slider